We started as a team of experts in protein production, crystallography and biophysics in 2005 with a mission to expedite structure-based drug discovery and with a vision “your discovery, our solutions”.

In 2016 we were acquired by WuXi AppTec, a company that provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. As part of the WuXi AppTec's HitS unit, we provide comprehensive target-to-hit discovery services of the highest quality, short timelines, and lower costs to enable diverse discovery organizations.

Our vision is that "every drug can be made and every disease can be treated".